Drug interaction study with catequentinib in healthy adults
Treatments studied
This study checks how a new investigational drug (catequentinib) interacts with two other common medications in healthy volunteers. Participation helps understand safe dosing and potential side effects before larger studies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 45 years old.
- You must be in good general health, with no serious medical conditions.
- Your body mass index (BMI) must be between 19 and 26.
- You must not have taken any prescription or over-the-counter medications, vitamins, or herbal remedies in the past 2 weeks.
- You must be willing to abstain from alcohol, smoking, and vigorous exercise during the study.
- You must agree to use effective birth control or abstain from sex for the duration of the study and six months after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing whether a common antifungal drug (itraconazole) affects how the body processes a new experimental medicine (HS-10506). The goal is to see if the two drugs can be used together safely.
This study looks at how a new medicine (Flonoltinib Maleate) interacts with other drugs in healthy adults. It helps doctors understand safe dosing and potential effects before the medicine is tested in patients.
This trial tests the safety of a new drug called KT-579 in healthy adults. It is the first time this drug is being given to humans. The study will help doctors understand how the drug works in the body and if it is safe.
This study checks how befotertinib, an experimental cancer drug, interacts with other drugs in healthy people. It helps make sure the drug is safe and works well when taken with other medicines.
This study checks if itraconazole changes how the body processes HSK31858. Healthy volunteers are needed to help understand the safety and drug levels.
This study tests a new drug (clifutinib) in healthy volunteers to see how other common medicines (itraconazole, fluconazole, and efavirenz) affect its levels in the body. The results will help doctors understand how to dose clifutinib in future patients.
Hear when a new Healthy Volunteer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.